Published in Proteomics Weekly, March 7th, 2005
Transition Technologies will be responsible for marketing, sales, installation and service for SpectruMedix products to academic, government and pharmaceutical research companies for the identification and discovery of genetic variation leading to disease and other health-related issues.
Reveal is a nonspecific detection method which enables the researcher to rapidly identify novel genetic variation. This method allows sample...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Proteomics Weekly